The Global AMS Accreditation Scheme is funded through a number of routes to ensure all organisations, regardless of their economic circumstances, can benefit from the scheme. Those organisations able to support the accreditation fees with pay directly, other organisations may be funded from BSAC charitable income and income generated by partnerships with external organisations. These partnerships are a powerful demonstration of how collaboration can positively impact healthcare, both by improving patient outcomes and contributing to a reduction in antimicrobial resistance. Further, accreditation serves as a strong motivator for staff and the award of accreditation highlights the outstanding work of colleagues across the globe.
Examples of successful collaborations are highlighted below and we are seeking to replicate these.
Addressing access disparities in healthcare
The BSAC and Pfizer’s collaborative project ‘Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities’, invited healthcare facilities around the world to submit project proposals detailing their specific resource limitation with respect to AMS and their plans for quality improvement work to address these. Teams were selected via a competitive review process and are working on their projects which will culminate with BSAC GAMSAS accreditation. You can see further details below.
Investment philanthropy
Baille Gifford, a private investment management company based in Edinburgh, provided a generous philanthropic donation to the Society to support activities that would address the burden of antimicrobial resistance. BSAC chose to use this funding to support the accreditation of a number of centres across the globe. The first of these centres was accredited in 2023. Lagos University Teaching Hospital (LUTH) was the first hospital in a low- to middle-income country, an the first in Africa, to receive Level 2 GAMSAS accreditation. LUTH are helping to raise the standard of healthcare by tackling antimicrobial resistance (AMR) through its participation in the scheme, critically important in the region since AMR is associated with more than a million deaths every year in Sub-Saharan Africa.
Botswana University of Pennsylvania Partnership
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico
Norton Healthcare Foundation, Kentucky USA
American University of Beirut, Lebanon
Mbarara University of science and Technology, Mbarara City, Uganda
Kenya Gertrude's Children's Hospital, Nairobi, Kenya